recombinant von Willebrand factor (vWF) [HSA:7450] [KO:K03900]
Prophylactic treatment of bleeding episodes and Von Willebrand disease
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B VITAMIN K AND OTHER HEMOSTATICS
B02BD Blood coagulation factors
B02BD10 von Willebrand factor
D08681 Vonicog alfa (USAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
634 Human blood preparations
6349 Others
D08681 Vonicog alfa (USAN); Vonicog alfa (genetical recombination) (JAN)
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02014 Blood coagulation accelerant
DG02013 Blood coagulation factor
D08681 Vonicog alfa
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D08681
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D08681
